WHO-UMC IDMP Management and Publish API
0.1.0 - CI Build International flag

WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions

Resource Profile: AdministrableProductDefinitionWhoPhP - Mappings

Active as of 2024-11-11

Mappings for the AdministrableProductDefinition-who-php resource profile.

Mappings for FiveWs Pattern Mapping (http://hl7.org/fhir/fivews)

AdministrableProductDefinitionWhoPhP
AdministrableProductDefinitionadministrative.medication
   containedadministrative.medication
   identifierFiveWs.class

Mappings for IDMP Mapping (https://www.iso.org/obp/ui/#iso:std:iso:11615)

AdministrableProductDefinitionWhoPhP
AdministrableProductDefinitionPharmaceutical Product
   containedIngredient
   identifierPhPID
   statusn/a
   ingredientPharmaceutical Product.Ingredient (see also FHIR Ingredient resource)
   descriptionn/a
   propertyPharmaceutical Product Characteristics
      typePharmaceutical Product Characteristics.Code System (not a one to one map, the resource is more capable)
      value[x]Pharmaceutical Product Characteristics.Value (not a one to one map, the resource is more capable)
      statusPharmaceutical Product Characteristics.Status
   routeOfAdministrationPharmaceutical Product.Route of Administration
      codeRoute of Administration.Route of Administration
      firstDoseDosing and Route of Administration.First dose in humans (Investigational Medicinal Product)
      maxSingleDoseDosing and Route of Administration.Maximum single dose (Investigational Medicinal Product)
      maxDosePerDayDosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product)
      maxDosePerTreatmentPeriodDosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product)
      maxTreatmentPeriodDosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product)
      targetSpeciesn/a
         coden/a
         withdrawalPeriodn/a
            tissuen/a
            valuen/a
            supportingInformationn/a

Mappings for RIM Mapping (http://hl7.org/v3)

AdministrableProductDefinitionWhoPhP
AdministrableProductDefinitionEntity, Role, or Act
   textAct.text?
   containedEntity, Role, or Act
   modifierExtensionN/A
   identifier
      idn/a
      extensionn/a
      useRole.code or implied by context
      typeRole.code or implied by context
      systemII.root or Role.id.root
      valueII.extension or II.root if system indicates OID or GUID (Or Role.id.extension or root)
      periodRole.effectiveTime or implied by context
      assignerII.assigningAuthorityName but note that this is an improper use by the definition of the field. Also Role.scoper
   property
      idn/a
      extensionn/a
      modifierExtensionN/A
   routeOfAdministration
      idn/a
      extensionn/a
      modifierExtensionN/A
      targetSpecies
         idn/a
         extensionn/a
         modifierExtensionN/A
         withdrawalPeriod
            idn/a
            extensionn/a
            modifierExtensionN/A